Further Delineation of Chromosomal Consensus Regions in Primary

Total Page:16

File Type:pdf, Size:1020Kb

Further Delineation of Chromosomal Consensus Regions in Primary Leukemia (2007) 21, 2463–2469 & 2007 Nature Publishing Group All rights reserved 0887-6924/07 $30.00 www.nature.com/leu ORIGINAL ARTICLE Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH) S Wessendorf1,6, TFE Barth2,6, A Viardot1, A Mueller3, HA Kestler3, H Kohlhammer1, P Lichter4, M Bentz5,HDo¨hner1,PMo¨ller2 and C Schwaenen1 1Klinik fu¨r Innere Medizin III, Zentrum fu¨r Innere Medizin der Universita¨t Ulm, Ulm, Germany; 2Institut fu¨r Pathologie, Universita¨t Ulm, Ulm, Germany; 3Forschungsdozentur Bioinformatik, Universita¨t Ulm, Ulm, Germany; 4Abt. Molekulare Genetik, Deutsches Krebsforschungszentrum, Heidelberg, Germany and 5Sta¨dtisches Klinikum Karlsruhe, Karlsruhe, Germany Primary mediastinal B-cell lymphoma (PMBL) is an aggressive the expression of BSAP, BOB1, OCT2, PAX5 and PU1 was extranodal B-cell non-Hodgkin’s lymphoma with specific clin- added to the spectrum typical of PMBL features.9 ical, histopathological and genomic features. To characterize Genetically, a pattern of highly recurrent karyotype alterations further the genotype of PMBL, we analyzed 37 tumor samples and PMBL cell lines Med-B1 and Karpas1106P using array- with the hallmark of chromosomal gains of the subtelomeric based comparative genomic hybridization (matrix- or array- region of chromosome 9 supported the concept of a unique CGH) to a 2.8k genomic microarray. Due to a higher genomic disease entity that distinguishes PMBL from other B-cell non- resolution, we identified altered chromosomal regions in much Hodgkin’s lymphomas.10,11 Together with less specific gains on higher frequencies compared with standard CGH: for example, 2p15 and frequent mutations of the SOCS1 gene, a notable þ 9p24 (68%), þ 2p15 (51%), þ 7q22 (32%), þ 9q34 (32%), genomic similarity to classical Hodgkin’s lymphoma was þ 11q23 (18%), þ 12q (30%) and þ 18q21 (24%). Moreover, 12–14 previously unknown small interstitial chromosomal low copy observed. The genetic overlap of the two entities has been number alterations (for example, À6p21, À11q13.3) and a total supported recently by the results of mRNA gene expressions 15–17 of 19 DNA amplifications were identified by array-CGH. For 17 studies. A number of critical genes, such as JAK2, REL, chromosomal localizations (10 gains and 7 losses), which were cMYC, MAL, PDL, SOCS1 and CDKN2A, have been discussed altered in more than 10% of the analyzed cases, we delineated to be involved in the pathogenesis of PMBL. However, the minimal consensus regions based on genomic base pair cascade of oncogenic events leading to PMBL is still elusive. The positions. These regions and selected immunohistochemistries detailed delineation of aberrant chromosomal regions using point to candidate genes that are discussed in the context of 18–23 NF-jB transcription activation, human leukocyte antigen class high-resolution, microarray-based genomic techniques I/II defects, impaired apoptosis and Janus kinase/signal allowing candidate gene identification provides a suitable tool transducer and activator of transcription (JAK/STAT) activation. for clarifying the genetic causes of this disease. Our data confirm the genomic uniqueness of this tumor and provide physically mapped genomic regions of interest for focused candidate gene analysis. Leukemia (2007) 21, 2463–2469; doi:10.1038/sj.leu.2404919; Materials and methods published online 30 August 2007 Keywords: mediastinal B-cell lymphoma; array-CGH; genomic Thirty-seven fresh, frozen tumor samples of PMBL were alterations included in the study. Histopathological diagnosis was based on morphologic and immunohistochemical criteria according to the WHO classification of malignant lymphomas1 by two expert hematopathologists (PM and TFEB). A total of 22 male and 15 female patients were analyzed. The median age was 36 years Introduction (for more details see Table 1). For all cases, chromosomal comparative genomic hybridization (cCGH) data along with Primary mediastinal B-cell lymphoma (PMBL) is a distinct selected fluorescent in situ hybridization and cytogenetic data clinicopathological entity in the WHO classification of non- were published earlier.11,12 However, for most cases of the 1 Hodgkin’s lymphomas (ICD-O: 9679/3). Due to the location analyzed series, sufficient material for systematic mRNA and morphologic characteristics, PMBL is a unique lymphoma expression analysis was not available any more. subset that probably derives primarily from asteroid thymic B For the construction of a 2800 targets comprising genomic 2–5 cells. PMBL is positive for CD19, CD20, CD45, and often microarray, a genome-wide distributed core set of DNA CD30, CD79a, CD11c, CD23 and negative for CD10 and fragments was selected out of the previously published, 6 CD21. Highly characteristic is a lack of immunoglobulin acknowledged ‘GoldenPath’ clone set. The targets were set at surface antigen and a missing expression of major histocompati- intervals of approximately 2 Mb across the entire human 7,8 bility complex (MHC) class I and II molecules. More recently, genome (alternating clones of the GoldenPath; in total 1500 clones). This compilation was supplemented with a set of 600 Correspondence: Dr S Wessendorf, Klinik fu¨r Innere Medizin III, DNA fragments, which focuses critical regions of B-cell Zentrum fu¨r Innere Medizin der Universita¨t Ulm, Robert-Koch-Strasse neoplasms as detected by previous cytogenetic studies, for 8, Ulm 89081, Germany. example, 2p13, 9p24 or 11q13. Finally, 699 DNA targets E-mail: [email protected] 6These authors contributed equally to this study. specific for, for example, proto-oncogenes or tumor suppressor Received 30 May 2007; revised 25 July 2007; accepted 26 July 2007; genes with discussed pathogenetic relevance in B-cell non- published online 30 August 2007 Hodgkin’s lymphoma were added. The final chip contained Array-CGH in primary mediastinal B-cell lymphoma S Wessendorf et al 2464 Table 1 Patient characteristics Clinical feature No. of patients Patients evaluable for characteristic Percentage Gender, male/female 22/15 37 59.5/40.5 Stage, XIII/IV 6 29 21 LDH elevated 20 27 74 WHO performance 4 27 15 Age, 460 years 3 37 8 Figure 1 Ideogram-based synopsis of all identified chromosomal imbalances for 37 analyzed tumor samples for chromosomes 1–22. Chromosomal gains (low copy number and amplifications) are indicated by green bars on the right of each ideogram, losses are indicated in red. Sites of known copy number polymorphisms (CNPs) are indicated as light blue dots on the right side of each ideogram. 2799 clones. A list of all clones with respective physical clone on the array was compared with the ‘Database of mapping information is given in Supplementary Table S1. Genomic Variants’ (http://www.projects.tcag.ca/variation/).26,27 DNA preparation of all bacterial artificial chromosome and P1- Clones and sites located in regions with known copy number derived artificial chromosome clones and subsequent sequential polymorphisms are marked in Figure 1 and in Supplementary degenerative oligonucleotide primer-mediated DNA amplifica- Table S1, enabling a conservative evaluation of the array data. tion was performed as described by Fiegler et al.,24,25 with three Alterations, which entirely covered CNPs, were excluded from minor modifications of the original protocol. A detailed descrip- the evaluation (for example, 5p11, 7q35, 14q32 and 15q11). For tion of the applied PCR procedures is listed in the supplement. the present study, the Y chromosome was excluded from the The PCR products were spotted onto Corning CMT-Gaps II glass analysis and the X chromosome was only evaluated with regard slides using an Omnigrid microarrayer (Gene Machines, San to DNA amplifications, since in all experiments, gender Carlos, CA, USA). DNA labeling, hybridization and data difference between tumor DNA and control DNA was used to acquisition were performed as described previously.21–23,25 monitor the integrity of each experiment. Fluorescence ratios were obtained using an Axon 4000 B dual laser scanner, computed as log2 ratios and normalized based on the linear clone set of 1500 clones (for details, see Schwaenen Results et al.21), excluding X and Y clones for normalization. There- upon, the ratios of two reverse color experiments were In 33 of the 37 (89%) tumor samples, a total of 199 averaged. The diagnostic cutoff level for each individual chromosomal imbalances were detected by array-CGH. The experiment was determined by calculating the mean and median number of aberrations was 5 (range ¼ 0–19). A total of subsequently using plus/minus three times the standard devia- 130 chromosomal gains and 69 losses were identified. In four tion of all clones from chromosomes 1–22. Additionally, those patients, no aberrations were found. Chromosomal gains in regions were scored as aberrant, whose signal ratios narrowly more than 10% of all cases (nX4) were detected on 9p24 missed the threshold criteria but were deviated unidirectionally (n ¼ 24), 2p15 (n ¼ 19), 7q22 (n ¼ 12), 12q (n ¼ 11), 11q13 in at least three adjacent targets. This was done to take into (n ¼ 7), 12p (n ¼ 6), 3q27 (n ¼ 5), 1q and 21q (both n ¼ 4). account aberrations of tumors with lower tumor cell fractions Genomic losses affected preferably 15q (n ¼ 6), 4q and 13q14 (for more details see Schwaenen et al.21). The cutoff value for (both n ¼ 5), and 8p, 6p21, 11q13 and 14q32 (all n ¼ 4). the detection of DNA amplifications was determined by Nineteen high-level DNA amplifications were identified by repetitive hybridizations of normal male vs normal female array-CGH localizing to (i) the previously described regions DNA. Due to the ratios for clones mapping to chromosome X in 2p15 (n ¼ 4); 9p24 (n ¼ 4) and X (n ¼ 3; see also annotations for these experiments, the cutoff ratio for amplifications was 1.6 (for Table 4 in which an overview of all DNA amplifications is details see Wessendorf et al.20).
Recommended publications
  • PAX5 Expression in Acute Leukemias: Higher B-Lineage Specificity Than Cd79a and Selective Association with T(8;21)-Acute Myelogenous Leukemia
    [CANCER RESEARCH 64, 7399–7404, October 15, 2004] PAX5 Expression in Acute Leukemias: Higher B-Lineage Specificity Than CD79a and Selective Association with t(8;21)-Acute Myelogenous Leukemia Enrico Tiacci,1 Stefano Pileri,2 Annette Orleth,1 Roberta Pacini,1 Alessia Tabarrini,1 Federica Frenguelli,1 Arcangelo Liso,3 Daniela Diverio,4 Francesco Lo-Coco,5 and Brunangelo Falini1 1Institutes of Hematology and Internal Medicine, University of Perugia, Perugia, Italy; 2Unit of Hematopathology, University of Bologne, Bologne, Italy; 3Section of Hematology, University of Foggia, Foggia, Italy; 4Department of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy; and 5Department of Biopathology, University Tor Vergata of Rome, Rome, Italy ABSTRACT (13, 16). PAX5 expression also occurs in the adult testis and in the mesencephalon and spinal cord during embryogenesis (17), suggesting an The transcription factor PAX5 plays a key role in the commitment of important role in the development of these tissues. hematopoietic precursors to the B-cell lineage, but its expression in acute Rearrangement of the PAX5 gene through reciprocal chromosomal leukemias has not been thoroughly investigated. Hereby, we analyzed routine biopsies from 360 acute leukemias of lymphoid (ALLs) and mye- translocations has been described in different types of B-cell malig- loid (AMLs) origin with a specific anti-PAX5 monoclonal antibody. Blasts nancies (18–23), and, more recently, PAX5 has also been shown to be from 150 B-cell ALLs showed strong PAX5 nuclear expression, paralleling targeted by aberrant hypermutation in Ͼ50% of diffuse large B-cell that of CD79a in the cytoplasm. Conversely, PAX5 was not detected in 50 lymphomas (24).
    [Show full text]
  • Genomic Profiling of Adult Acute Lymphoblastic Leukemia by Single
    SUPPLEMENTARY APPENDIX Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia Ryoko Okamoto,1 Seishi Ogawa,2 Daniel Nowak,1 Norihiko Kawamata,1 Tadayuki Akagi,1,3 Motohiro Kato,2 Masashi Sanada,2 Tamara Weiss,4 Claudia Haferlach,4 Martin Dugas,5 Christian Ruckert,5 Torsten Haferlach,4 and H. Phillip Koeffler1,6 1Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA; 2Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; 3Department of Stem Cell Biology, Graduate School of Medical Science, Kanazawa University 4MLL Munich Leukemia Laboratory, Munich, Germany; 5Department of Medical Informatics and Biomathematics, University of Münster, Münster, Germany; 6Cancer Science Institute of Singapore, National University of Singapore, Singapore Citation: Okamoto R, Ogawa S, Nowak D, Kawamata N, Akagi T, Kato M, Sanada M, Weiss T, Haferlach C, Dugas M, Ruckert C, Haferlach T, and Koeffler HP. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonu- cleotide microarray and comparison to pediatric acute lymphoblastic leukemia. Haematologica 2010;95(9):1481-1488. doi:10.3324/haematol.2009.011114 Online Supplementary Data ed by PCR of genomic DNA and subsequent direct sequencing of SNP in a region of CNN-LOH in an ALL sample versus the corresponding Design and Methods matched normal sample (Online Supplementary
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A PAX5-OCT4-PRDM1 Developmental Switch Specifies Human Primordial Germ Cells
    A PAX5-OCT4-PRDM1 Developmental Switch Specifies Human Primordial Germ Cells Fang Fang1,2, Benjamin Angulo1,2, Ninuo Xia1,2, Meena Sukhwani3, Zhengyuan Wang4, Charles C Carey5, Aurélien Mazurie5, Jun Cui1,2, Royce Wilkinson5, Blake Wiedenheft5, Naoko Irie6, M. Azim Surani6, Kyle E Orwig3, Renee A Reijo Pera1,2 1Department of Cell Biology and Neurosciences, Montana State University, Bozeman, MT 59717, USA 2Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA 3Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, School of Medicine; Magee Women’s Research Institute, Pittsburgh, PA, 15213, USA 4Genomic Medicine Division, Hematology Branch, NHLBI/NIH, MD 20850, USA 5Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. 6Wellcome Trust Cancer Research UK Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, UK. Correspondence should be addressed to F.F. (e-mail: [email protected]) 1 Abstract Dysregulation of genetic pathways during human germ cell development leads to infertility. Here, we analyzed bona fide human primordial germ cells (hPGCs) to probe the developmental genetics of human germ cell specification and differentiation. We examined distribution of OCT4 occupancy in hPGCs relative to human embryonic stem cells (hESCs). We demonstrate that development, from pluripotent stem cells to germ cells, is driven by switching partners with OCT4 from SOX2 to PAX5 and PRDM1. Gain- and loss-of-function studies revealed that PAX5 encodes a critical regulator of hPGC development. Moreover, analysis of epistasis indicates that PAX5 acts upstream of OCT4 and PRDM1. The PAX5-OCT4-PRDM1 proteins form a core transcriptional network that activates germline and represses somatic programs during human germ cell differentiation.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Retinoic Acid Induces Sertoli Cell Paracrine Signals for Spermatogonia Differentiation but Cell Autonomously Drives Spermatocyte Meiosis
    Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosis Mathilde Raverdeaua, Aurore Gely-Pernota, Betty Féreta, Christine Dennefelda, Gérard Benoitb, Irwin Davidsona, Pierre Chambona,1, Manuel Marka,c, and Norbert B. Ghyselincka,1 aInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7104, Institut National de la Santé et de la Recherche Médicale Unité 964, Université de Strasbourg, F-67404 Illkirch Cedex, France; bCentre de Génétique et de Physiologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5534, Université de Lyon 1, F-69622 Villeurbanne Cedex, France; and cHôpitaux Universitaires de Strasbourg, F-67091 Strasbourg Cedex, France Contributed by Pierre Chambon, August 29, 2012 (sent for review July 26, 2012) Direct evidence for a role of endogenous retinoic acid (RA), the active a recent study showing that female GC can enter meiosis in a fetal metabolite of vitamin A in the initial differentiation and meiotic entry ovary devoid of RA has challenged this model (6). of spermatogonia, and thus in the initiation of spermatogenesis is still During embryonic development RA usually acts in a paracrine lacking. RA is synthesized by dedicated enzymes, the retinaldehyde manner, one cell type controlling its synthesis, whereas a neigh- dehydrogenases (RALDH), and binds to and activates nuclear RA bor cell type responds to the signal (7). In cells synthesizing RA, receptors (RARA, RARB, and RARG) either within the RA-synthesizing conversion of retinol to its active metabolite depends upon ret- cells or in the neighboring cells.
    [Show full text]
  • Targeted Resequencing Identifies Genes with Recurrent Variation In
    www.nature.com/npjgenmed ARTICLE OPEN Targeted resequencing identifies genes with recurrent variation in cerebral palsy C. L. van Eyk 1,2, M. A. Corbett 1,2, M. S. B. Frank 1,2, D. L. Webber1,2, M. Newman3, J. G. Berry 1,2, K. Harper1,2, B. P. Haines1,2, G. McMichael1,2, J. A. Woenig1,2, A. H. MacLennan1,2 and J. Gecz 1,2,4* A growing body of evidence points to a considerable and heterogeneous genetic aetiology of cerebral palsy (CP). To identify recurrently variant CP genes, we designed a custom gene panel of 112 candidate genes. We tested 366 clinically unselected singleton cases with CP, including 271 cases not previously examined using next-generation sequencing technologies. Overall, 5.2% of the naïve cases (14/271) harboured a genetic variant of clinical significance in a known disease gene, with a further 4.8% of individuals (13/271) having a variant in a candidate gene classified as intolerant to variation. In the aggregate cohort of individuals from this study and our previous genomic investigations, six recurrently hit genes contributed at least 4% of disease burden to CP: COL4A1, TUBA1A, AGAP1, L1CAM, MAOB and KIF1A. Significance of Rare VAriants (SORVA) burden analysis identified four genes with a genome-wide significant burden of variants, AGAP1, ERLIN1, ZDHHC9 and PROC, of which we functionally assessed AGAP1 using a zebrafish model. Our investigations reinforce that CP is a heterogeneous neurodevelopmental disorder with known as well as novel genetic determinants. npj Genomic Medicine (2019) ; https://doi.org/10.1038/s41525-019-0101-z4:27 1234567890():,; INTRODUCTION is likely also due in part to the stringent criteria used to select Cerebral palsy (CP) is the most common motor disability of causative variants.
    [Show full text]
  • Original Article Diagnostic and Prognostic Values of Forkhead Box D4 Gene in Colonic Adenocarcinoma
    Int J Clin Exp Pathol 2020;13(10):2615-2627 www.ijcep.com /ISSN:1936-2625/IJCEP0117403 Original Article Diagnostic and prognostic values of forkhead box D4 gene in colonic adenocarcinoma Qiu-Xia Li1, Ning-Qin Li2, Jin-Yuan Liao2 1Department of Health Management and Division of Physical Examination, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People’s Republic of China; 2Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People’s Republic of China Received July 2, 2020; Accepted August 31, 2020; Epub October 1, 2020; Published October 15, 2020 Abstract: Previous studies found that Forkhead box D4 (FOXD4) overexpressed in human colorectal cancer had the worst prognosis. However, the diagnostic value and further mechanism have not been fully researched. Statistical examinations for FOXD4 expression colon adenocarcinoma (COAD) patients were obtained from The Cancer Genome Atlas (TCGA). Survival analysis was used to assess its prognostic value. Nomogram model was used for visual pre- diction of patient survival rate. The online functional enrichment analysis tool was used to evaluate the biological functions and pathways of FOXD4 and its co-expressed genes. Receiver operating characteristic curve analysis suggested that FOXD4 might be a diagnostic biomarker for COAD (P<0.001, area under the curve [AUC]=0.728, 95% confidence interval [CI]=0.669-0.787). Low expression ofFOXD4 was associated with a good clinical outcome (P=0.001, HR=0.517, 95% CI=0.341-0.782). A total of 797 genes were correlated with FOXD4 and associated with cell proliferation, cell differentiation, nuclear matrix, Rap1 signaling pathway, RNA transport, and VEGF signaling pathway.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • Repressing the Repressor: Fra1 Controls Plasma Cell Generation
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 20 Editorial Repressing the repressor: Fra1 controls plasma cell generation Dirk Mielenz , Bettina Grötsch and Jean-Pierre David B cell differentiation from the early commitment become quickly up-regulated upon B cell activation [5]. into the B lymphoid lineage in the bone marrow up In addition, c-Fos had been shown to promote Blimp1 to the differentiation into antibody secreting plasma expression [6]. However, the physiological relevance cells is tightly controlled by a transcriptional program of these observations was not demonstrated in vivo. We dominated by a cascade of repression. Indeed, each recently showed by gain and loss of function experiments step of B cell differentiation to mature B cells appears that Fra1 enhances activation induced cell death (AICD) to depend on transcription factors that, in addition to upon its induction in activated B cells, and as well limits promoting differentiation, repress key determinants of B cell proliferation [7]. Moreover, transgenic over- other hematopoietic lineages or even key regulators of expression of Fra1 blocks plasma cell differentiation the next or previous steps of B cell differentiation. For and immunoglobulin production in vitro and in vivo. instance, Pax5 that is required for early B cell commitment In accordance, mice with B cell-specific deletion of and maintenance of B cell identity acts by repressing the Fra1 show enhanced plasma cell differentiation in vitro differentiation of lymphoid precursor cells into the other and in vivo as well as exacerbated antibody responses. hematopoietic lineages [1]. Globally, key transcriptional Interestingly, transgenic Bcl2 overexpression alleviated regulators of B cell identity such as Pax5, Bcl6 or Bach2, Fra1 elicited AICD and corrected the B cell proliferation all inhibit the generation of antibody secreting plasma defect.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]